Locke Lord advised Nutex Health Inc. on the deal. Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system...
You must be a Standard 1 Year member to access this content.
Locke Lord advised Chicago Pacific Founders on the deal. P3 Health Partners Inc. (Nasdaq: PIII), a patient-centered and physician-led population health management company (the “Company”), announced...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Doximity on the deal. Doximity (NYSE: DOCS) announced its initial public offering of 23,300,000 shares of its Class A common stock at a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised the initial purchasers on the deal. Rapid7, Inc. (Nasdaq: RPD) announced the Rule 144A offering of $525 million principal amount of its 0.25% Convertible...
You must be a Standard 1 Year member to access this content.
